TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23564304

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-based pediatric obesity prevention intervention
Number of subjects: 253
Study: 20679904

Group type: EXPERIMENTAL
Intervention: 5 mg ilaprazole
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 10 mg ilaprazole
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: 20 mg ilaprazole
Number of subjects: 235

Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 235
Study: 19413179

Group type: EXPERIMENTAL
Intervention: PTRA followed by IVBT
Number of subjects: 62

Group type: COMPARATOR
Intervention: PTRA alone
Number of subjects: 62
Study: 16834791

Group type: EXPERIMENTAL
Intervention: Meptazinol (2.5 mg kg‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.3 mg kg‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fentanyl (5 microg kg‐1)
Number of subjects: 75
Study: 15704320

Group type: EXPERIMENTAL
Intervention: LifeSite Hemodialysis System with 70% isopropyl alcohol as the antimicrobial solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal jugular vein placement with positioning of the valve on the anterior chest wall
Number of subjects: 0
Study: 11697835

Group type: EXPERIMENTAL
Intervention: Oral capecitabine 1,255 mg/m2 twice daily (two weeks' treatment followed by a one-week rest period)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Intravenous CMF (cyclophosphamide, methotrexate, 5-fluorouracil) administered every three weeks
Number of subjects: 95
Study: 9208260

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal controls (before treatment)
Number of subjects: 8
Study: 8434830

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine (prophylactic use)
Number of subjects: 0
Study: 3497638

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP‐1 Serono)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 31305281

Group type: EXPERIMENTAL
Intervention: Carvedilol ± Ivabradine (THR group A)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard care (control group B)
Number of subjects: 189
Study: 30305092

Group type: EXPERIMENTAL
Intervention: Otic gel containing 1% florfenicol, 1% terbinafine and 0.1% betamethasone acetate applied twice with a one‐week interval
Number of subjects: 286

Group type: COMPARATOR
Intervention: Suspension containing hydrocortisone aceponate, miconazole and gentamicin administered daily for 5 days
Number of subjects: 286

Group type: COMPARATOR
Intervention: Both groups (otic gel and suspension)
Number of subjects: 286
Study: 26741257

Group type: EXPERIMENTAL
Intervention: Synchronized movements during unintended coordination tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unintended interpersonal coordination task with manipulated synchronization and richness
Number of subjects: 0
Study: 25588519

Group type: EXPERIMENTAL
Intervention: 5HTT polymorphism (short group)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: 5HTT polymorphism (long group)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 228
Study: 22015960

Group type: EXPERIMENTAL
Intervention: Enhanced physician care with care management (n=32)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Enhanced physician care only (n=25)
Number of subjects: 57
Study: 20870116

Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral corneal relaxing incisions
Number of subjects: 0
Study: 18184678

Group type: EXPERIMENTAL
Intervention: Controlled heated breathing tube humidifier (ThermoSmart(R))
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional heated humidification
Number of subjects: 19
Study: 16720430

Group type: EXPERIMENTAL
Intervention: Glycine
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 15566051

Group type: EXPERIMENTAL
Intervention: Participation in after school programs (ASPs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in after school programs (ASPs) with high emphasis on social skills and character development
Number of subjects: 0
Study: 11230037

Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 708

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 708
Study: 9036753

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 8345370

Group type: EXPERIMENTAL
Intervention: General anesthesia with 30 micrograms/kg intravenous (i.v.) alfentanil, 2.5 mg/kg i.v. thiopental, and 0.1 mg/kg i.v. vecuronium, maintained with 0.5 microgram/kg/min alfentanil, nitrous oxide (N2O) 67% in oxygen, and 0.8 microgram/kg/min vecuronium.
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Adjunctive therapy with one of three different treatment modalities (20 to 60 micrograms/kg i.v. alfentanil, 0.5 to 2.0% inspired isoflurane, or 0.05 to 0.15 mg/kg i.v. trimethaphan).
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Preincision EEG‐SEF and LECI values.
Number of subjects: 89
Study: 3946979

Group type: EXPERIMENTAL
Intervention: Dialysate Ca concentration of 7.5 mg/dL
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dialysate Ca concentration of 5.5 mg/dL
Number of subjects: 12
Study: 28812151

Group type: EXPERIMENTAL
Intervention: EUS-guided biopsy sampling (EUS-FNB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Fine needle aspiration (EUS-FNA)
Number of subjects: 70
Study: 27919256

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 302
Study: 25330687

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg-norgestimate 250 mcg-ethinyl estradiol 35 microg (Group A)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Cyproterone acetate 12 mg-ethinyl estradiol 35 microg (Group B)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Norgestimate 250 mcg-ethinyl estradiol 35 microg (Group C)
Number of subjects: 167
Study: 23031562

Group type: EXPERIMENTAL
Intervention: LND + RE (low energy, low CP diet with 50 mg/kg NSP-hydrolysing enzyme)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: HND + RE (high energy, high CP diet with 50 mg/kg NSP-hydrolysing enzyme)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: HND (high energy, high CP diet)
Number of subjects: 200

Group type: COMPARATOR
Intervention: LND (low energy, low CP diet)
Number of subjects: 200
Study: 19818694

Group type: EXPERIMENTAL
Intervention: Azithromycin 5mg/kg/day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Azithromycin 15mg/kg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 56
Study: 18338628

Group type: EXPERIMENTAL
Intervention: Herbal CONSORT statement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) theory
Number of subjects: 0
Study: 16807259

Group type: EXPERIMENTAL
Intervention: NTM-positive patients
Number of subjects: 98

Group type: COMPARATOR
Intervention: NTM-negative patients
Number of subjects: 98
Study: 14606738

Group type: EXPERIMENTAL
Intervention: Motor Relearning Programme
Number of subjects: 61

Group type: COMPARATOR
Intervention: Bobath
Number of subjects: 61
Study: 10094119

Group type: EXPERIMENTAL
Intervention: Metyrapone (MET)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Metyrapone (MET) and Graded Maximal Exercise Test (GXT)
Number of subjects: 16
Study: 8665377

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets (ITBN)
Number of subjects: 11000
Study: 1890364

Group type: EXPERIMENTAL
Intervention: Mixture of heat‐killed Mycobacterium leprae and BCG
Number of subjects: 29000

Group type: COMPARATOR
Intervention: BCG alone
Number of subjects: 29000
Study: 6388916

Group type: EXPERIMENTAL
Intervention: Budesonide (freon propellant device - Rhinocort) 400 micrograms daily
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Budesonide (water solution in mechanical pump spray) 400 micrograms daily
Number of subjects: 118

Group type: COMPARATOR
Intervention: Budesonide (water solution in mechanical pump spray) 200 micrograms daily
Number of subjects: 118
Study: 28961958

Group type: EXPERIMENTAL
Intervention: Online life review therapy with online counseling
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Online life review therapy with online peer support
Number of subjects: 58

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 58
Study: 30355101

Group type: EXPERIMENTAL
Intervention: Higher neutrophil levels with ICAS
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Lower neutrophil levels without ICAS
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Any hemorrhage at 90 days
Number of subjects: 1034
Study: 25846401

Group type: EXPERIMENTAL
Intervention: Curved abutments (experimental)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional abutments (control)
Number of subjects: 26
Study: 24713181

Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 108
Study: 21688195

Group type: EXPERIMENTAL
Intervention: BIA-guided ultrafiltration
Number of subjects: 135

Group type: COMPARATOR
Intervention: Clinical-guided ultrafiltration
Number of subjects: 135
Study: 20559467

Group type: EXPERIMENTAL
Intervention: Air-conducted vestibular evoked myogenic potentials (AC-VEMPs)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Bone-conducted vestibular evoked myogenic potentials (BC-VEMPs)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Air-bone gap (ABG)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Bone-conduction 4-frequency pure tone average (4-PTA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Air-conducted 4-frequency pure tone average (4-PTA)
Number of subjects: 41
Study: 17537772

Group type: EXPERIMENTAL
Intervention: Beta-lactam macrolide combination therapy
Number of subjects: 451

Group type: COMPARATOR
Intervention: Beta-lactam alone monotherapy
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Matched groups (27 patients each from monotherapy and combination therapy)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 451
Study: 16612523

Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12002966

Group type: EXPERIMENTAL
Intervention: Computer-assisted communication (which combined verbal and computerized communication)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Verbal communication
Number of subjects: 79
Study: 10068095

Group type: EXPERIMENTAL
Intervention: Interferon monotherapy (6 months)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Interferon monotherapy (up to 12 months)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Interferon-ribavirin combination therapy (6 months)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: HCV RNA test at week 4
Number of subjects: 376
Study: 8830203

Group type: EXPERIMENTAL
Intervention: Codeine phosphate (50 mg), given 4 times daily for 3 days starting 2 hours after surgery (Trial 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Codeine phosphate (50 mg), given 4 times daily for 3 days starting 3 hours after surgery (Trial 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Codeine phosphate (50 mg)
Number of subjects: 40
Study: 2187380

Group type: EXPERIMENTAL
Intervention: Vasodilators
Number of subjects: 0
Study: 6775298

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (NGS) 0.75 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment (NGO) 15 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 6
Study: 31982649

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30621791

Group type: EXPERIMENTAL
Intervention: AIMhi Stay Strong App
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control app intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 28712490

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (1.5mg/kg/day, max 50mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26823335

Group type: COMPARATOR
Intervention: HRV administered at 6 and 10 weeks (group 1)
Number of subjects: 456

Group type: COMPARATOR
Intervention: HRV administered at 10 and 14 weeks (group 2)
Number of subjects: 456

Group type: COMPARATOR
Intervention: HRV administered at 6, 10, and 14 weeks (group 3)
Number of subjects: 456
Study: 24668767

Group type: EXPERIMENTAL
Intervention: Kripalu-based yoga intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Assessment control group
Number of subjects: 38
Study: 22781186

Group type: EXPERIMENTAL
Intervention: Ginger (500 mg capsules of ginger root powder, three times a day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (500 mg capsules, three times a day)
Number of subjects: 120
Study: 19038375

Group type: EXPERIMENTAL
Intervention: 350‐mm(2) Baerveldt glaucoma implant (tube group)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC) (trabeculectomy group)
Number of subjects: 55
Study: 17549745

Group type: EXPERIMENTAL
Intervention: Bedside procedure service offered to physicians from 1 of 3 firms for 4 weeks
Number of subjects: 1941

Group type: COMPARATOR
Intervention: Control group (firms not offered the bedside procedure service)
Number of subjects: 1941

Group type: EXPERIMENTAL
Intervention: Bedside procedure service
Number of subjects: 1941
Study: 15659722

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 2521

Group type: COMPARATOR
Intervention: ICD therapy
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2521
Study: 11926711

Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV) plus standard medical therapy (ST)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard medical therapy (ST) alone
Number of subjects: 34
Study: 9524991

Group type: EXPERIMENTAL
Intervention: Choice group (male latex condoms and nonoxynol‐9 film)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Condom group (male latex condoms only)
Number of subjects: 167
Study: 8088297

Group type: EXPERIMENTAL
Intervention: anti-regurgitation formula with thickening product, positional treatment, parental reassurance
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo (same formula without thickening product, positional treatment, parental reassurance)
Number of subjects: 20
Study: 2764265

Group type: EXPERIMENTAL
Intervention: Pentaglobin (10 g daily on the 3rd, 4th, and 5th day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Human albumin (12.5 g daily on the 3rd, 4th, and 5th day)
Number of subjects: 50
Study: 29986444

Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - participated in the MHL promotion program (two sessions, 90 min each) delivered at one-week intervals.
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control Group (CG) - did not participate in the MHL promotion program.
Number of subjects: 543
Study: 27606566

Group type: EXPERIMENTAL
Intervention: Enamelon® Preventive Treatment Gel (EPTG) with 0.4% stannous fluoride
Number of subjects: 52

Group type: COMPARATOR
Intervention: Biotene® Oral Balance Gel (BOBG)
Number of subjects: 52
Study: 25608984

Group type: EXPERIMENTAL
Intervention: Topical leek extract cream
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard antihemorrhoid cream
Number of subjects: 20
Study: 22940055

Group type: EXPERIMENTAL
Intervention: 75 cGy 131-Iodine tositumomab with high-dose BEAM (carmustine, etoposide, cytarabine, and melphalan) followed by autologous stem cell transplantation
Number of subjects: 40
Study: 20556439

Group type: EXPERIMENTAL
Intervention: Tubular discectomy
Number of subjects: 216

Group type: COMPARATOR
Intervention: Conventional microdiscectomy
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 216
Study: 18358926

Group type: EXPERIMENTAL
Intervention: Tocilizumab 8 mg/kg
Number of subjects: 623

Group type: EXPERIMENTAL
Intervention: Tocilizumab 4 mg/kg
Number of subjects: 623

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 623
Study: 16818865

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Community treatment by experts
Number of subjects: 101
Study: 14616415

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg once daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 18
Study: 11506057

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CP) supplementation at 400 microg/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 44
Study: 10205417

Group type: EXPERIMENTAL
Intervention: Systematic Training for Effective Parenting (STEP)
Number of subjects: 18
Study: 7531022

Group type: EXPERIMENTAL
Intervention: ECT plus transcatheter hepatic artery infusion chemotherapy (TAI) and embolisation (IAE) treatment (Group B)
Number of subjects: 74

Group type: COMPARATOR
Intervention: ECT only (Group A)
Number of subjects: 74

Group type: COMPARATOR
Intervention: ECT plus systemic chemotherapy (Group C)
Number of subjects: 74
Study: 3278764

Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (oxerutin; 'Paroven', 'Venoruton', Zyma) 3 g/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30975645

Group type: EXPERIMENTAL
Intervention: Steroid (methylprednisolone 40 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 132
Study: 28480412

Group type: EXPERIMENTAL
Intervention: liver‐softening medicine plus glucosamine
Number of subjects: 40

Group type: COMPARATOR
Intervention: glucosamine alone
Number of subjects: 40
Study: 25003998

Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide coated bioactive stents (BAS)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Both BAS and EES
Number of subjects: 827
Study: 23993865

Group type: EXPERIMENTAL
Intervention: Continuation of maintenance medication
Number of subjects: 178

Group type: COMPARATOR
Intervention: Discontinuation of medication
Number of subjects: 178
Study: 21477372

Group type: EXPERIMENTAL
Intervention: Complex education program (video, brochure, individual training by a practice nurse)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Brochure only (control group)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Complex education program
Number of subjects: 360
Study: 18566802

Group type: EXPERIMENTAL
Intervention: (R)-[(11)C]mirtazapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (S)-[(11)C]mirtazapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (R)-mirtazapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: (S)-mirtazapine
Number of subjects: 0
Study: 16831520

Group type: EXPERIMENTAL
Intervention: 100 microg estrogen transdermally for 3 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12742438

Group type: EXPERIMENTAL
Intervention: Poly-acid modified resin composite/resin composite (PMRC/RC) sandwich restoration
Number of subjects: 29

Group type: COMPARATOR
Intervention: Direct resin composite (RC) restoration
Number of subjects: 29
Study: 10668836

Group type: EXPERIMENTAL
Intervention: Amlodipine therapy
Number of subjects: 825

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study: 9059201

Group type: EXPERIMENTAL
Intervention: Tepid bypass (35-36 degrees C)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hypothermic bypass (30 degrees C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 29117091

Group type: EXPERIMENTAL
Intervention: Expert demonstrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novice demonstrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of both expert and novice demonstrations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27281726

Group type: EXPERIMENTAL
Intervention: Thoracic epidural block
Number of subjects: 80
Study: 24817827

Group type: EXPERIMENTAL
Intervention: VivaSight™ single lumen endotracheal tube
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional endotracheal tube
Number of subjects: 72
Study: 23087249

Group type: EXPERIMENTAL
Intervention: CVC team intervention (experimental unit)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard care (control unit)
Number of subjects: 82
Study: 19841767

Group type: EXPERIMENTAL
Intervention: Ceram.X/K‐0127
Number of subjects: 43

Group type: COMPARATOR
Intervention: Tetric Ceram/Syntac Classic
Number of subjects: 43
Study: 16783669

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (Group K: n=22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline infusion (Group S: n=23)
Number of subjects: 45
Study: 15250188

Group type: EXPERIMENTAL
Intervention: Distractor task (completing addition problems)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Distractor task (viewing addition problems)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Distractor task (viewing a blank slide)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Arousal (high and low)
Number of subjects: 36
Study: 11262503

Group type: EXPERIMENTAL
Intervention: Dissonance-based intervention
Number of subjects: 87

Group type: COMPARATOR
Intervention: Healthy weight management control group
Number of subjects: 87
Study: 9040209

Group type: EXPERIMENTAL
Intervention: Endoanal ultrasound performed by two experienced investigators with two different ultrasound machines
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Endoanal ultrasound performed by two investigators independently using a single ultrasound machine in three standardized positions
Number of subjects: 19
Study: 7696447

Group type: EXPERIMENTAL
Intervention: Budesonide enema, 2 mg/100 mL (Entocort)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Hydrocortisone acetate foam enema, 125 mg (Colifoam)
Number of subjects: 72
Study: 2431838

Group type: EXPERIMENTAL
Intervention: Theophylline (600 mg daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Enprofylline (600 mg daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24